1Pedersen SE, Hurd SS, Lemanske RF, et al. Global strategy for the diagnosis and management of asthma in children 5 years and younger[J]. Pediatr Pulmonol, 2011,46(1) : 1-17.
2Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology [J]. Chest, 2005, 127 ( 1 ) : 335-371.
4Dundaroz R, Erenberk U, Turel O, et al. Oxidative and antioxida-tire status of children with acute bronchiolitis [ J ]. J Pediatr ( Rio J), 2013, 89 (4): 407-411.
5Jorquera PA, Anderson L, Tripp RA. Understanding respiratory syn- cytial virus (RSV) vaccine development and aspects of disease patho- genesis [J]. Expert Rev Vaccines, 2016, 15 (2) : 173-187.
6DerHovanessian A, Weigt SS, Palchevskiy V, et al. The Role of TGF-!3 in the association between primary graft dysfunction and bron- chiolitis obliterans syndrome [ J]. Am J Transplant, 2016, 16 (2) : 640-649.
7Lin J, Tang Y, Xiu Q, et al. Real-life effectiveness of budesonide/ formoterol therapy in asthma : a suhanalysis of the SMARTASIA study [J]. Allergy Asthma Proc, 2016, 37 (1) : 27-34.
8Muoz - Quiles C, L6pez - Lacort M, tlbeda - Sansano I, et al. Population-based analysis of bronchiolitis epidemiology in Va- lencia, Spain [ J ]. Pediatr Infect Dis J, 2016,35 ( 3 ) : 275 - 280.
9Carroll WD,Srinivas J.Bronchodilators in wheezy under 2-year-olds:when and which(if any)[J].Arch Dis Child Educ Pract Ed,2013,98:113-118.
10Gadomski AM,Brower M.Bronchodilators for bronchiolitis[J].Cochrane Database Syst Rev,2010,8(12):CD001266.
